MICREOS SECURES €12 MILLION FOR NEW PRODUCTS CAN.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    Biotech Financial Reports. Mar2016, Vol. 23 Issue 3, p5-6. 2p.
  • Subject Terms:
    ANTIBACTERIAL agents
  • Additional Information
    • Subject Terms:
      MICREOS (Company)
    • Abstract:
      The article discusses the release of the secured antibacterial lysin technology Staphefekt from phage technology development company Micreos.